672 related articles for article (PubMed ID: 32946194)
1. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Epps QJ; Epps KL; Zobell JT; Young DC
Pediatr Pulmonol; 2020 Dec; 55(12):3541-3572. PubMed ID: 32946194
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
3. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
4. State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary.
Epps QJ; Epps KL; Young DC; Zobell JT
Pediatr Pulmonol; 2021 Jul; 56(7):1825-1837. PubMed ID: 33656280
[TBL] [Abstract][Full Text] [Related]
5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
[TBL] [Abstract][Full Text] [Related]
6. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
[TBL] [Abstract][Full Text] [Related]
8. Allergic bronchopulmonary aspergillosis in children.
Manti S; Parisi GF; Papale M; Licari A; Chiappini E; Mulè E; Rotolo N; Leonardi S
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():20-22. PubMed ID: 33236425
[TBL] [Abstract][Full Text] [Related]
9. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
Nepomuceno IB; Esrig S; Moss RB
Chest; 1999 Feb; 115(2):364-70. PubMed ID: 10027433
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis.
Hayes D; Murphy BS; Lynch JE; Feola DJ
Pediatr Pulmonol; 2010 Nov; 45(11):1145-8. PubMed ID: 20658484
[TBL] [Abstract][Full Text] [Related]
11. Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.
Casciaro R; Naselli A; Cresta F; Ros M; Castagnola E; Minicucci L
J Chemother; 2015 Oct; 27(5):307-11. PubMed ID: 24824366
[TBL] [Abstract][Full Text] [Related]
12. Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
Hassanzad M; Mortezaee V; Bongomin F; Poorabdollah M; Sharifynia S; Maleki M; Hedayati N; Velayati AA; Hedayati MT
J Mycol Med; 2019 Jun; 29(2):189-192. PubMed ID: 30782501
[TBL] [Abstract][Full Text] [Related]
13. Beyond the Guidelines: Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Tompkins MG; Pettit R
Ann Pharmacother; 2022 Feb; 56(2):181-192. PubMed ID: 34078140
[TBL] [Abstract][Full Text] [Related]
14. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review.
Moreira AS; Silva D; Ferreira AR; Delgado L
Clin Exp Allergy; 2014 Oct; 44(10):1210-27. PubMed ID: 24809846
[TBL] [Abstract][Full Text] [Related]
15. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD010288. PubMed ID: 34550603
[TBL] [Abstract][Full Text] [Related]
16. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Francis NZ; Southern KW
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002204. PubMed ID: 36053129
[TBL] [Abstract][Full Text] [Related]
17. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2014 Nov; (11):CD002204. PubMed ID: 25431975
[TBL] [Abstract][Full Text] [Related]
18. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2012 Jun; (6):CD002204. PubMed ID: 22696329
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review.
Parisi GF; Portale A; Papale M; Tardino L; Rotolo N; Licari A; Leonardi S
J Allergy Clin Immunol Pract; 2019; 7(5):1636-1638. PubMed ID: 30772479
[No Abstract] [Full Text] [Related]
20. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick H; Southern K
Cochrane Database Syst Rev; 2000; (4):CD002204. PubMed ID: 11034746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
